Related Experiment Video
Updated: Apr 19, 2026
07:48
Staining Protocols for Human Pancreatic Islets
Published on: May 23, 2012
27.9K
Islet inflammation in human type 1 diabetes mellitus
Noel G Morgan1, Pia Leete, Alan K Foulis
1Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, UK.
IUBMB Life
|December 16, 2014
Summary
Type 1 diabetes (T1DM) involves immune cells attacking pancreatic beta cells. Patients show distinct immune profiles (hyper-immune or pauci-immune), influencing beta-cell loss rate and disease onset age.
Area of Science:
- Immunology
- Endocrinology
- Pathology
Background:
- Type 1 diabetes mellitus (T1DM) results from pancreatic beta-cell destruction by immune cells.
- The precise cellular and molecular mechanisms of beta-cell loss in human T1DM remain incompletely understood.
- Studying islet inflammation in T1DM is challenging due to limited access to living patient tissues and pathological specimens.
Purpose of the Study:
- To review current understanding of T1DM aetiology.
- To highlight established features of islet infiltrate composition.
- To identify areas of ongoing ambiguity and debate in T1DM pathogenesis.
Main Methods:
- Analysis of islet infiltrate composition in recent-onset T1DM pathological specimens.
- Characterization of immune cell populations, including CD8+ T cells, CD4+ T cells, and CD20+ B cells.
- Categorization of patients into distinct phenotypes based on CD20 expression levels (hyper-immune vs. pauci-immune).
Main Results:
- Islet infiltrate is primarily lymphocytic, with autoreactive CD8+ and CD4+ T cells targeting islet antigens.
- CD20+ B cells are often present, with patient populations exhibiting either high (CD20Hi) or low (CD20Lo) B cell infiltration.
- A correlation exists between immune phenotype and disease progression: hyper-immune patients experience faster beta-cell decline and earlier disease onset.
Conclusions:
- T1DM pathogenesis involves specific immune cell interactions within the pancreas.
- Distinct patient phenotypes (hyper-immune vs. pauci-immune) characterize T1DM and impact disease trajectory.
- Further research is needed to fully elucidate the complex mechanisms driving beta-cell loss in T1DM.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
6
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
6
01:12Type I Diabetes I: Introduction
6
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
6
01:22Diabetes Mellitus: Overview and Type I Subtype
6.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.5K
01:19Type I Diabetes III: Clinical Manifestations
9
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
9
01:26Type II Diabetes I: Introduction
2
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2
01:24Type II Diabetes II: Pathophysiology
2
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2